Display options
Share it on

Acta Pharm Sin B. 2016 Jan;6(1):55-63. doi: 10.1016/j.apsb.2015.11.001. Epub 2015 Dec 15.

Development and validation of an HPLC-MS/MS method to determine clopidogrel in human plasma.

Acta pharmaceutica Sinica. B

Gangyi Liu, Chunxia Dong, Weiwei Shen, Xiaopei Lu, Mengqi Zhang, Yuzhou Gui, Qinyi Zhou, Chen Yu

Affiliations

  1. Central Laboratory, Shanghai Clinical Center, Chinese Academy of Sciences/Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai 200031, China.
  2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai 200233, China.

PMID: 26904399 PMCID: PMC4724691 DOI: 10.1016/j.apsb.2015.11.001

Abstract

A quantitative method for clopidogrel using online-SPE tandem LC-MS/MS was developed and fully validated according to the well-established FDA guidelines. The method achieves adequate sensitivity for pharmacokinetic studies, with lower limit of quantifications (LLOQs) as low as 10 pg/mL. Chromatographic separations were performed on reversed phase columns Kromasil Eternity-2.5-C18-UHPLC for both methods. Positive electrospray ionization in multiple reaction monitoring (MRM) mode was employed for signal detection and a deuterated analogue (clopidogrel-d 4) was used as internal standard (IS). Adjustments in sample preparation, including introduction of an online-SPE system proved to be the most effective method to solve the analyte back-conversion in clinical samples. Pooled clinical samples (two levels) were prepared and successfully used as real-sample quality control (QC) in the validation of back-conversion testing under different conditions. The result showed that the real samples were stable in room temperature for 24 h. Linearity, precision, extraction recovery, matrix effect on spiked QC samples and stability tests on both spiked QCs and real sample QCs stored in different conditions met the acceptance criteria. This online-SPE method was successfully applied to a bioequivalence study of 75 mg single dose clopidogrel tablets in 48 healthy male subjects.

Keywords: Back-conversion; Bioequivalence; Clopidogrel; Deuterated analogue; ESI, electrospray ionization; FDA guidelines; IS, internal standard; LC–MS/MS; LC–MS/MS, liquid chromatography tandem mass spectrometry; LLOQ, lower limit of quantification; MRM, multiple reaction monitoring; Online-SPE; QC, quality control; Real samples stability; SPE, solid phase extraction

References

  1. Clin Ther. 2010 Jan;32(1):161-70 - PubMed
  2. J Am Coll Cardiol. 2006 Oct 3;48(7):1339-45 - PubMed
  3. Clin Ther. 2009 Apr;31(4):793-803 - PubMed
  4. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 15;878(30):3134-42 - PubMed
  5. Arzneimittelforschung. 2004 Sep;54(9A):600-4 - PubMed
  6. J Pharm Biomed Anal. 2008 Dec 1;48(4):1219-24 - PubMed
  7. Thromb Res. 2009 Jun;124(2):193-8 - PubMed
  8. J Chromatogr B Biomed Sci Appl. 1998 Dec 11;720(1-2):107-17 - PubMed
  9. Eur J Cardiothorac Surg. 2004 Jul;26(1):96-101 - PubMed
  10. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):344-54 - PubMed
  11. J Am Coll Cardiol. 2005 Feb 1;45(3):369-76 - PubMed

Publication Types